MULTIDRUG RESISTANT DYSLIPIDEMIA: A CASE REPORT
Anno:
2024
Introduction: Recently introduced lipid-lowering agents (PCSK9-i, bempedoic acid) can efficiently treat statin-intolerant patients, who couldn ‘t reach LDL target before. Nonetheless, there are still cases where the pharmacological management may have strong limitations. Case report: A 71 year-old woman, with multiple cardiovascular risk factors (diabetes, hypertension and familial dylipidemia,…